BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 37743131)

  • 1. Pathogenesis-based application of biologics for chronic rhinosinusitis: Current and future perspectives.
    Okano M; Kanai K; Oka A
    Auris Nasus Larynx; 2024 Apr; 51(2):371-378. PubMed ID: 37743131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologics for chronic rhinosinusitis.
    Chong LY; Piromchai P; Sharp S; Snidvongs K; Philpott C; Hopkins C; Burton MJ
    Cochrane Database Syst Rev; 2020 Feb; 2(2):CD013513. PubMed ID: 32102112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chinese Expert Consensus on the Use of Biologics in Patients with Chronic Rhinosinusitis (2022, Zhuhai).
    Hong HY; Chen TY; Yang QT; Sun YQ; Chen FH; Lou HF; Wang HT; Yu RL; An YF; Liu F; Wang TS; Lu MP; Qiu QH; Wang XD; Chen JJ; Meng CD; Xie ZH; Meng J; Zeng M; Xu CL; Wang Y; Yang YC; Zhang WT; Tang J; Yang YL; Xu R; Yu GD; Shi ZH; Wei X; Ye HP; Sun YN; Yu SQ; Zhang TH; Yong J; Hang W; Xu YT; Xu Y; Tan GL; Sun N; Yang G; Li YJ; Ye J; Zuo KJ; Zhang LQ; Wang XY; Yang AN; Xu YX; Liao W; Fan YP; Li HB
    ORL J Otorhinolaryngol Relat Spec; 2023; 85(3):128-140. PubMed ID: 37019094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologics for chronic rhinosinusitis.
    Chong LY; Piromchai P; Sharp S; Snidvongs K; Webster KE; Philpott C; Hopkins C; Burton MJ
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013513. PubMed ID: 33710614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologics in chronic rhinosinusitis with nasal polyposis.
    Laidlaw TM; Buchheit KM
    Ann Allergy Asthma Immunol; 2020 Apr; 124(4):326-332. PubMed ID: 31830587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Biologics in Chronic Rhinosinusitis With Nasal Polyps.
    Patel GB; Peters AT
    Ear Nose Throat J; 2021 Jan; 100(1):44-47. PubMed ID: 33035132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updates on current evidence for biologics in chronic rhinosinusitis.
    Nasta MS; Chatzinakis VA; Georgalas CC
    Curr Opin Otolaryngol Head Neck Surg; 2020 Feb; 28(1):18-24. PubMed ID: 31789925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Biologics in the Treatment of Nasal Polyps.
    Franzese CB
    Immunol Allergy Clin North Am; 2020 May; 40(2):295-302. PubMed ID: 32278452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement in Smell Using Monoclonal Antibodies Among Patients With Chronic Rhinosinusitis With Nasal Polyps: A Systematic Review.
    Barroso B; Valverde-Monge M; Betancor D; Gómez-López A; Villalobos-Vilda C; González-Cano B; Sastre J
    J Investig Allergol Clin Immunol; 2023 Dec; 33(6):419-430. PubMed ID: 37669083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis.
    Striz I; Golebski K; Strizova Z; Loukides S; Bakakos P; Hanania NA; Jesenak M; Diamant Z
    Clin Sci (Lond); 2023 May; 137(9):727-753. PubMed ID: 37199256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving predictability of IgE-high type 2 chronic sinusitis with nasal polyps in the biologic era.
    Heffernan A; Phulka J; Thamboo A
    J Otolaryngol Head Neck Surg; 2022 May; 51(1):22. PubMed ID: 35606866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of Dupilumab Versus Omalizumab in Chronic Rhinosinusitis With Nasal Polyps and Asthma: EVEREST Trial Design.
    De Prado Gomez PharmD MSc L; Khan Mbbs Mph AH; Peters Md AT; Bachert Md PhD C; Wagenmann Md M; Heffler Md PhD E; Hopkins BMBCh C; Hellings Md PhD PW; Zhang PhD M; Xing PhD J; Rowe Md P; Jacob-Nara Md Mph DHSc JA
    Am J Rhinol Allergy; 2022 Nov; 36(6):788-795. PubMed ID: 35837739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologics for chronic rhinosinusitis with nasal polyps.
    Bachert C; Zhang N; Cavaliere C; Weiping W; Gevaert E; Krysko O
    J Allergy Clin Immunol; 2020 Mar; 145(3):725-739. PubMed ID: 32145872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biologic Therapies for Allergic Rhinitis and Nasal Polyposis.
    Geng B; Dilley M; Anterasian C
    Curr Allergy Asthma Rep; 2021 Jun; 21(6):36. PubMed ID: 34110505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The argument against the use of dupilumab in patients with limited polyp burden in chronic rhinosinusitis with nasal polyposis (CRSwNP).
    Hardison SA; Senior BA
    J Otolaryngol Head Neck Surg; 2023 Sep; 52(1):64. PubMed ID: 37759322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endotype-driven precision medicine in chronic rhinosinusitis.
    Lou H; Wang C; Zhang L
    Expert Rev Clin Immunol; 2019 Nov; 15(11):1171-1183. PubMed ID: 31600458
    [No Abstract]   [Full Text] [Related]  

  • 17. Benefits of biologic therapy administered for asthma on co-existent chronic rhinosinusitis: A real-world study.
    Bajpai S; Marino MJ; Rank MA; Donaldson AM; O'Brien EK; Lal D
    Int Forum Allergy Rhinol; 2021 Aug; 11(8):1152-1161. PubMed ID: 33527730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse events of biological therapy in chronic rhinosinusitis with nasal polyps: A systematic review.
    Aldajani A; Alroqi A; Alromaih S; Aloulah MO; Alsaleh S
    Am J Otolaryngol; 2022; 43(6):103615. PubMed ID: 36057193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic rhinosinusitis with nasal polyps (CRSwNP) treated with omalizumab, dupilumab, or mepolizumab: A systematic review of the current knowledge towards an attempt to compare agents' efficacy.
    Papacharalampous GX; Constantinidis J; Fotiadis G; Zhang N; Bachert C; Katotomichelakis M
    Int Forum Allergy Rhinol; 2024 Jan; 14(1):96-109. PubMed ID: 37394893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Biologics in the Treatment of Chronic Rhinosinusitis.
    Haloob N; Karamali K; Hopkins C
    BioDrugs; 2023 Jul; 37(4):477-487. PubMed ID: 37318659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.